Progress and Prospects: Gene Therapy Clinical Trials (Part 1)
- 1 October 2007
- journal article
- review article
- Published by Springer Science and Business Media LLC in Gene Therapy
- Vol. 14 (20), 1439-1447
- https://doi.org/10.1038/sj.gt.3303001
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Phase I Trial of Intramuscular Injection of a Recombinant Adeno-Associated Virus Serotype 2α1-Antitrypsin (AAT) Vector in AAT-Deficient AdultsHuman Gene Therapy, 2006
- Restoration of vision in RPE65-deficient Briard dogs using an AAV serotype 4 vector that specifically targets the retinal pigmented epitheliumGene Therapy, 2006
- Adenoviral Vector-Delivered Pigment Epithelium-Derived Factor for Neovascular Age-Related Macular Degeneration: Results of a Phase I Clinical TrialHuman Gene Therapy, 2006
- Response of Retinoblastoma With Vitreous Tumor Seeding to Adenovirus-Mediated Delivery of Thymidine Kinase Followed by GanciclovirJournal of Clinical Oncology, 2005
- Regional intravascular delivery of AAV-2-F.IX to skeletal muscle achieves long-term correction of hemophilia B in a large animal modelBlood, 2005
- Administration of a Replication-Deficient Adeno-Associated Virus Gene Transfer Vector Expressing the HumanCLN2cDNA to the Brain of Children with Late Infantile Neuronal Ceroid LipofuscinosisHuman Gene Therapy, 2004
- Gene therapy for chronic granulomatous diseaseExpert Opinion on Biological Therapy, 2004
- LMO2 -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1Science, 2003
- Clinical Protocol: Phase I Clinical Trial Utilizing Gene Therapy for Limb Girdle Muscular Dystrophy: alpha-, beta-, gamma-, or delta-Sarcoglycan Gene Delivered with Intramuscular Instillations of Adeno-Associated VectorsHuman Gene Therapy, 2000
- Retroviral Transfer of the Glucocerebrosidase Gene into CD34+ Cells from Patients with Gaucher Disease: In Vivo Detection of Transduced Cells without MyeloablationHuman Gene Therapy, 1998